filmov
tv
Immunotherapy: Moving beyond PD1 and PDL1 inhibitors
![preview_player](https://i.ytimg.com/vi/HgdzUpWM4vk/maxresdefault.jpg)
Показать описание
In this presentation from the 22nd Annual Perspectives in Thoracic Oncology, Dr. Vassiliki A. Papadimitrakopoulou discusses immunotherapy in lung cancer beyond PDF1 and PDL1 inhibitors.
© 2017 Imedex, LLC.